Top

Published in:

01-10-2013

Ultrasound-Targeted Microbubble Destruction Enhances Human β-Defensin 3 Activity Against Antibiotic-Resistant Staphylococcus Biofilms

Authors: Chen Zhu, Nianan He, Tao Cheng, Honglue Tan, Yongyuan Guo, Desheng Chen, Mengqi Cheng, Zhi Yang, Xianlong Zhang

Published in: Inflammation | Issue 5/2013

Abstract

The infection of orthopedic implantation devices with Staphylococcus is a serious concern within the biomaterial community. Treatments are not always successful because of antibiotic-resistant bacteria and serious biofilm infections. Human β-defensin 3 (hBD-3) is considered to be the most promising class of defensin antimicrobial peptides and its effect on antibiotic-resistant Staphylococcus biofilms, combined with ultrasound (US)-targeted microbubble (MB) destruction (UTMD), has not been reported. In the study, we found that biofilm densities, the percentage of live cells and the viable counts of two tested Staphylococcus recovered from the biofilm were significantly decreased in the maximum concentration hBD-3 combined with UTMD compared with those of any other groups. Furthermore, results suggested that UTMD could also enhance 1MIC hBD-3 activity inhibiting the biofilm-associated genes expression of icaAD and the methicillin-resistance genes expression of MecA by simultaneously promoting the icaR expression. UTMD may have great potential for improving antibiotic activity against biofilm infections.

Darouiche, R.O. 2004. Treatment of infections associated with surgical implants. The New England Journal of Medicine 350: 1422–1429.PubMedCrossRef

Montanaro, L., P. Speziale, D. Campoccia, S. Ravaioli, I. Cangini, G. Pietrocola, S. Giannini, and C.R. Arciola. 2011. Scenery of Staphylococcus implant infections in orthopedics. Future Microbiology 6: 1329–1349.PubMedCrossRef

Campoccia, D., L. Montanaro, P. Speziale, and C.R. Arciola. 2010. Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. Biomaterials 31: 6363–6377.PubMedCrossRef

Shi, Z., K.G. Neoh, E.T. Kang, C. Poh, and W. Wang. 2009. Titanium with surface-grafted dextran and immobilized bone morphogenetic protein-2 for inhibition of bacterial adhesion and enhancement of osteoblast functions. Tissue Engineering. Part A 15: 417–426.PubMedCrossRef

Blum-Menezes, D., O.J. Bratfich, M.C. Padoveze, and M.L. Moretti. 2009. Hospital strain colonization by Staphylococcus epidermidis. Brazilian Journal of Medical and Biological Research 42: 294–298.PubMedCrossRef

Patel, Z.M., P.H. Hwang, A. Chernomorsky, D.T. Bravo, B.L. Nguyen, K. Nesterova, and J.V. Nayak. 2012. Low-frequency pulsed ultrasound in the nasal cavity and paranasal sinuses: A feasibility and distribution study. International Forum of Allergy Rhinology 2: 303–308.PubMedCrossRef

Dijkmans, P.A., L.J. Juffermans, R.J. Musters, A. van Wamel, F.J. ten Cate, W. van Gilst, C.A. Visser, N. de Jong, and O. Kamp. 2004. Microbubbles and ultrasound: From diagnosis to therapy. European Journal of Echocardiography 5: 245–256.PubMedCrossRef

He, N., J. Hu, H. Liu, T. Zhu, B. Huang, X. Wang, Y. Wu, W. Wang, and D. Qu. 2011. Enhancement of vancomycin activity against biofilms by using ultrasound-targeted microbubble destruction. Antimicrobial Agents and Chemotherapy 55: 5331–5337.PubMedCrossRef

Qin, Z., X. Yang, L. Yang, J. Jiang, Y. Ou, S. Molin, and D. Qu. 2007. Formation and properties of in vitro biofilms of ica-negative Staphylococcus epidermidis clinical isolates. Journal of Medical Microbiology 56: 83–93.PubMedCrossRef

10.

Hancock, R.E. 2005. Mechanism of action of newer antibiotics for Gram-positive pathogens. The Lancet Infectious Diseases 5: 209–218.PubMedCrossRef

11.

Harder, J., J. Bartels, E. Christophers, and J.M. Schroder. 2001. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. Journal of Biological Chemistry 276: 5707–5713.PubMedCrossRef

12.

Maisetta, G., G. Batoni, S. Esin, W. Florio, D. Bottai, F. Favilli, and M. Campa. 2006. In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains. Antimicrobial Agents and Chemotherapy 50: 806–809.PubMedCrossRef

13.

Warnke, P.H., I.N. Springer, P.A. Russo, J. Wiltfang, H. Essig, M. Kosmahl, E. Sherry, and Y. Acil. 2006. Innate immunity in human bone. Bone 38: 400–408.PubMedCrossRef

14.

Huang, Q., H.J. Yu, G.D. Liu, X.K. Huang, L.Y. Zhang, Y.G. Zhou, J.Y. Chen, F. Lin, Y. Wang, and J. Fei. 2012. Comparison of the effects of human β-defensin 3, Vancomycin, and Clindamycin on Staphylococcus aureus biofilm formation. Orthopedics 35: e53–e60.PubMedCrossRef

15.

Zhu, C., H. Tan, T. Cheng, H. Shen, J. Shao, Y. Guo, S. Shi, and X. Zhang. 2012. Human β-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation. Journal of Surgical Research. doi:10.1016/j.jss.2012.11.048.

16.

Nihonyanagi, S., Y. Kanoh, K. Okada, T. Uozumi, Y. Kazuyama, T. Yamaguchi, N. Nakazaki, K. Sakurai, Y. Hirata, S. Munekata, S. Ohtani, T. Takemoto, Y. Bandoh, and T. Akahoshi. 2012. Clinical usefulness of multiplex PCR lateral flow in MRSA detection: a novel, rapid genetic testing method. Inflammation 35: 927–934.PubMedCrossRef

17.

Arciola, C.R., D. Campoccia, L. Baldassarri, M.E. Donati, V. Pirini, S. Gamberini, and L. Montanaro. 2006. Detection of biofilm formation in Staphylococcus epidermidis from implant infections: Comparison of a PCR method that recognizes the presence of ica genes with two classic phenotypic methods. Journal of Biomedical Materials Research. Part A 76: 425–430.PubMedCrossRef

18.

Quaia, E., F. Calliada, M. Bertolotto, S. Rossi, L. Garioni, L. Rosa, and R. Pozzi-Mucelli. 2004. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: Diagnostic performance and confidence. Radiology 232: 420–430.PubMedCrossRef

19.

van der Plas, M.J., G.N. Jukema, S.W. Wai, H.C. Dogterom-Ballering, E.L. Lagendijk, C. van Gulpen, J.T. van Dissel, G.V. Bloemberg, and P.H. Nibbering. 2008. Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 61: 117–122.PubMedCrossRef

20.

Kim, H.J., J.F. Greenleaf, R.R. Kinnick, J.T. Bronk, and M.E. Bolander. 1996. Ultrasound-mediated transfection of mammalian cells. Hum. Gene Therapy 7: 1339–1346.CrossRef

21.

Li, M., D.J. Cha, Y. Lai, A.E. Villaruz, D.E. Sturdevant, and M. Otto. 2007. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Molecular Microbiology 66: 1136–1147.PubMedCrossRef

22.

Bjerkan, G., E. Witsø, and K. Bergh. 2009. Sonication is superior to scraping for retrieval of bacteria in biofilm on titanium and steel surfaces in vitro. Acta Orthopaedica 80: 245–250.PubMedCrossRef

23.

Peng, Z.X., B. Tu, Y. Shen, L. Du, L. Wang, S.R. Guo, and T.T. Tang. 2011. Quaternized chitosan inhibits icaA transcription and biofilm formation by staphylococcus on a titanium surface. Antimicrobial Agents and Chemotherapy 55: 860–866.PubMedCrossRef

24.

Tan, H., Z. Peng, Q. Li, X. Xu, S. Guo, and T. Tang. 2012. The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus. Biomaterials 33: 365–377.PubMedCrossRef

25.

Rohde, H., S. Frankenberger, U. Zähringer, and D. Mack. 2011. Structure, function and contribution of polysaccharide intercellular adhesin (PIA) to Staphylococcus epidermidis biofilm formation and pathogenesis of biomaterial-associated infections. European Journal of Cell Biology 89: 103–111.CrossRef

26.

Jeng, W.Y., T.P. Ko, C.I. Liu, R.T. Guo, C.L. Liu, H.L. Shr, and A.H. Wang. 2008. Crystal structureof IcaR, a repressor of the TetR family implicated in biofilm formation in Staphylococcus epidermidis. Nucleic Acids Research 36: 1567–1577.PubMedCrossRef

27.

Katayama, Y., T. Ito, and K. Hiramatsu. 2000. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 44: 1549–1555.PubMedCrossRef

28.

Runyan, C.M., J.C. Carmen, B.L. Beckstead, J.L. Nelson, R.A. Robison, and W.G. Pitt. 2006. Low-frequency ultrasound increases outer membrane permeability of Pseudomonas aeruginosa. Journal of General and Applied Microbiology 52: 295–301.PubMedCrossRef

29.

Carmen, J.C., J.L. Nelson, B.L. Beckstead, C.M. Runyan, R.A. Robison, G.B. Schaalje, and W.G. Pitt. 2004. Ultrasonic-enhanced gentamicin transport through colony biofilms of Pseudomonas aeruginosa and Escherichia coli. Journal of Infection and Chemotherapy 10: 193–199.PubMedCrossRef

30.

Juffermans, L.J., P.A. Dijkmans, R.J. Musters, C.A. Visser, and O. Kamp. 2006. Transient permeabilization of cell membranes by ultrasound-exposed microbubbles is related to formation of hydrogen peroxide. American Journal of Physiology - Heart and Circulatory Physiology 291: H1595–H1601.PubMedCrossRef

31.

Li, P., Y. Zheng, H. Ran, J. Tan, Y. Lin, Q. Zhang, J. Ren, and Z. Wang. 2012. Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice. Journal of Controlled Release 162: 349–354.PubMedCrossRef

32.

Moosavi Nejad, S., S.H. Hosseini, H. Akiyama, and K. Tachibana. 2011. Optical observation of cell sonoporation with low intensity ultrasound. Biochemical and Biophysical Research Communications 413: 218–223.PubMedCrossRef

33.

Han, Y.W., A. Ikegami, P. Chung, L. Zhang, and C.X. Deng. 2007. Sonoporation is an efficient tool for intracellular fluorescent dextran delivery and one-step double-crossover mutant construction in Fusobacterium nucleatum. Applied and Environmental Microbiology 73: 3677–3683.PubMedCrossRef

34.

Nishikawa, T., A. Yoshida, A. Khanal, M. Habu, I. Yoshioka, K. Toyoshima, T. Takehara, T. Nishihara, K. Tachibana, and K. Tominaga. 2010. A study of the efficacy of ultrasonic waves in removing biofilms. Gerodontology 27: 199–206.PubMedCrossRef

35.

Xu, J., T.A. Bigelow, L.J. Halverson, J.M. Middendorf, and B. Rusk. 2012. Minimization of treatment time for in vitro 1.1 MHz destruction of Pseudomonas aeruginosa biofilms by high-intensity focused ultrasound. Ultrasonics 52: 668–675.PubMedCrossRef

36.

Santamato, A., V. Solfrizzi, F. Panza, G. Tondi, V. Frisardi, B.G. Leggin, M. Ranieri, and P. Fiore. 2009. Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: A randomized clinical trial. Physical Therapy 89: 643–652.PubMedCrossRef

37.

Yu, H., S. Chen, and P. Cao. 2012. Synergistic bactericidal effects and mechanisms of low intensity ultrasound and antibiotics against bacteria: A review. Ultrasonics Sonochemistry 19: 377–382.PubMedCrossRef

38.

Maisetta, G., F.L. Brancatisano, S. Esin, M. Campa, and G. Batoni. 2011. Gingipains produced by Porphyromonas gingivalis ATCC49417 degrade human-β-defensin 3 and affect peptide's antibacterial activity in vitro. Peptides 32: 1073–1077.PubMedCrossRef

39.

Maisetta, G., M. Di Luca, S. Esin, W. Florio, F.L. Brancatisano, D. Bottai, M. Campa, and G. Batoni. 2008. Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3. Peptides 29: 1–6.PubMedCrossRef

40.

Hengge, U.R. 2006. Gene therapy progress and prospects: The skin—easily accessible, but still far away. Gene Therapy 13: 1555–1563.PubMedCrossRef

41.

Yu, Q., R.I. Lehrer, and J.P. Tam. 2000. Engineered salt-insensitive alpha defensins with end-to -end circularizeed structures. Journal of Biological Chemistry 275: 3943–3949.PubMedCrossRef

42.

Hirsch, T., M. Spielmann, B. Zuhaili, M. Fossum, M. Metzig, T. Koehler, H.U. Steinau, F. Yao, A.B. Onderdonk, L. Steinstraesser, and E. Eriksson. 2009. Human beta-defensin-3 promotes wound healing in infected diabetic wounds. The Journal of Gene Medicine 11: 220–228.PubMedCrossRef

43.

Gibson, A.L., C.L. Thomas-Virnig, J.M. Centanni, S.J. Schlosser, C.E. Johnston, K.F. Van Winkle, A. Szilagyi, L.K. He, R. Shankar, and B.L. Allen-Hoffmann. 2012. Nonviral human beta defensin-3 expression in a bioengineered human skin tissue: A therapeutic alternative for infected wounds. Wound Repair and Regeneration 20: 414–424.PubMedCrossRef

Title: Ultrasound-Targeted Microbubble Destruction Enhances Human β-Defensin 3 Activity Against Antibiotic-Resistant Staphylococcus Biofilms
Authors: Chen Zhu
Nianan He
Tao Cheng
Honglue Tan
Yongyuan Guo
Desheng Chen
Mengqi Cheng
Zhi Yang
Xianlong Zhang
Publication date: 01-10-2013
Publisher: Springer US
Published in: Inflammation / Issue 5/2013
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-013-9630-2

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Ultrasound-Targeted Microbubble Destruction Enhances Human β-Defensin 3 Activity Against Antibiotic-Resistant Staphylococcus Biofilms

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2013

Continuous Renal Replacement Therapy (CRRT) Attenuates Myocardial Inflammation and Mitochondrial Injury Induced by Venovenous Extracorporeal Membrane Oxygenation (VV ECMO) in a Healthy Piglet Model

Association Between Gene Polymorphisms of IRAK-M and the Susceptibility of Sepsis

Alterations in NK Cell Phenotype in Relation to Liver Steatosis in Children with Chronic Hepatitis C

Magnolol Inhibits LPS-Induced Inflammatory Response in Uterine Epithelial Cells

TLR4 Mediates MAPK–STAT3 Axis Activation in Bladder Epithelial Cells

The Protective Effect of Recombinant FomA-expressing Lactobacillus acidophilus Against Periodontal Infection

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page